drugset / Trial / NCT00467987

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

NCT00467987 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the effects of testosterone deficiency in men with diabetes on atherogenesis, inflammation, cardiovascular Risk factors And adiposity .

Timeline

Start
2007-06-01
Primary completion
2018-03-01
Completion
2018-10-11

Outcome

Outcome not reported

Stopped: “Company no longer making same drug doses.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule — —